chr21-41250859-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1
The NM_012105.5(BACE2):c.1092C>T(p.Asp364=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.405 in 1,613,088 control chromosomes in the GnomAD database, including 140,400 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.34 ( 10798 hom., cov: 32)
Exomes 𝑓: 0.41 ( 129602 hom. )
Consequence
BACE2
NM_012105.5 synonymous
NM_012105.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.23
Genes affected
BACE2 (HGNC:934): (beta-secretase 2) This gene encodes an integral membrane glycoprotein that functions as an aspartic protease. The encoded protein cleaves amyloid precursor protein into amyloid beta peptide, which is a critical step in the etiology of Alzheimer's disease and Down syndrome. The protein precursor is further processed into an active mature peptide. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 21-41250859-C-T is Benign according to our data. Variant chr21-41250859-C-T is described in ClinVar as [Benign]. Clinvar id is 3060688.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-1.23 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.682 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BACE2 | NM_012105.5 | c.1092C>T | p.Asp364= | synonymous_variant | 7/9 | ENST00000330333.11 | |
BACE2 | NM_138992.3 | c.1092C>T | p.Asp364= | synonymous_variant | 7/8 | ||
BACE2 | XM_017028314.2 | c.807C>T | p.Asp269= | synonymous_variant | 8/10 | ||
BACE2 | NM_138991.3 | c.984+4796C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BACE2 | ENST00000330333.11 | c.1092C>T | p.Asp364= | synonymous_variant | 7/9 | 1 | NM_012105.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.343 AC: 52131AN: 151974Hom.: 10794 Cov.: 32
GnomAD3 genomes
AF:
AC:
52131
AN:
151974
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.451 AC: 113307AN: 251230Hom.: 27954 AF XY: 0.455 AC XY: 61755AN XY: 135760
GnomAD3 exomes
AF:
AC:
113307
AN:
251230
Hom.:
AF XY:
AC XY:
61755
AN XY:
135760
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.411 AC: 600851AN: 1460996Hom.: 129602 Cov.: 39 AF XY: 0.415 AC XY: 301943AN XY: 726868
GnomAD4 exome
AF:
AC:
600851
AN:
1460996
Hom.:
Cov.:
39
AF XY:
AC XY:
301943
AN XY:
726868
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.343 AC: 52134AN: 152092Hom.: 10798 Cov.: 32 AF XY: 0.352 AC XY: 26156AN XY: 74332
GnomAD4 genome
AF:
AC:
52134
AN:
152092
Hom.:
Cov.:
32
AF XY:
AC XY:
26156
AN XY:
74332
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2073
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
BACE2-related disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 30, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at